Dr. Reddy's Laboratories Limited (RDY) Financials

RDY Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 6.0 billion 2.1 billion
Dec. 31, 2025 6.3 billion 2.1 billion
Sept. 30, 2025 6.1 billion 2.0 billion
June 30, 2025 6.1 billion 1.9 billion

RDY Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 114.3 million ?
Dec. 31, 2025 39.9 million 222500
Sept. 30, 2025 61.2 million 1.1 million
June 30, 2025 52.3 million 1.3 million

RDY Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 23.8 million
Dec. 31, 2025 132.4 million
Sept. 30, 2025 160.6 million
June 30, 2025 164.5 million

RDY Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 915.1 million 127.2 million -
Dec. 31, 2025 918.8 million - 151.8 million
Sept. 30, 2025 785.8 million 131.0 million 152.9 million
June 30, 2025 778.1 million - 75.4 million

RDY Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 ?
Dec. 31, 2025 9.3 million
Sept. 30, 2025 9.4 million
June 30, 2025 9.7 million

RDY Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 49.8 million 59.0 million 299.7 million -
Dec. 31, 2025 81.4 million 68.4 million 299.5 million -
Sept. 30, 2025 114.1 million 69.8 million 297.6 million -
June 30, 2025 118.4 million 72.9 million 270.5 million -

RDY Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 811.5 million 447.7 million
Dec. 31, 2025 970.9 million 450.1 million
Sept. 30, 2025 991.1 million 449.2 million
June 30, 2025 997.1 million 429.7 million

RDY

Price: $13.24

52 week price:
12.19
16.17

Dividend Yield: 0.69%

5-year range yield:
0.14%
0.79%

Forward Dividend Yield: 0.63%

Payout Ratio: 24.14%

Payout Ratio Range:
-9.05%
6392.29%

Dividend Per Share: 0.08 USD

Earnings Per Share: 0.53 USD

P/E Ratio: 25.83

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: India

Volume: 129000

Ebitda: 142.4 million

Market Capitalization: 11.0 billion

Average Dividend Frequency: 1

Years Paying Dividends: 24

DGR3: -8.82%

DGR5: 30.00%

DGR10: 30.00%

Links: